basic skin diseases of the human body. it describes the basic lesions not he advanced diseases.
It is a disease affecting reticuloendothelial cells of the skin
caused by protozoan Leishmania,
transmitted by the bite of female sand fly
There is an interplay of leishmania protozoa between
An educational presentation that consists of general complaint of skin diseases, history taking and examining various lesions and differentiating it and lastly tools required and investigation to be done to diagnose the skin manifestations
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
3. Primary skin lesions
Fundamental morphological
changes
Macule: Flat, non-palpable
circumscribed area of change in
skin colour <10mm in diameter
eg: flat nevi
Patch: circumscribed flat
discoloration > 1cm in diameter
eg vitiligo, tinea versicolor
4. Papule: small, circumscribed elevation of skin <1cm
in diameter
Eg. Measles
Plaque: Palpable, plateau-like elevation of skin >1cm
in diameter Eg. Psoriasis
Nodule: Palpable, solid, round or ellipsoidal lesion
(with depth) <1cm in diameter, in the dermis or
subcutaneous fat. Eg. Erythema nodosum
Tumour: >1cm diameter Eg. Nevus
Primary skin lesions:
5. Vesicle: Circumscribed, elevated
lesion <1cm in diameter,
containing serous (clear) fluid eg.
HSV
Bulla: Blisters of diameter >1cm
Eg. Pemphigus
Pustule: a superficial, elevated
lesion with pus eg. Folliculitis
Primary skin lesions:
6. Petechiae: small, pinpoint <2mm
red, non-blanching macule from
extravasated blood
Purpura: larger red, brown or
purple raised, non-blanching patch
or plaque of extravasated blood
Ecchymoses: When extensive
Hematoma: Raised ecchymoses
Eg. Bleeding disorders
Primary skin lesions:
7. Wheal: An elevated, transient,
compressible papule or plaque
of dermal edema Eg. Urticaria
Exanthem: Eruption on skin
with inflammatory changes
Enanthem: Eruption on
mucous membrane
Primary skin lesions:
8. Secondary skin lesions:
Scale: Dry flake of stratum
corneum
Crust: a dry mass of exudate,
serum, dried blood, scales, pus
Ulcer: a clearly defined, deep
erosion of the epidermis and at
least papillary dermis
9. Scar: a permanent skin change resulting
from formation of fibrous tissue after
destruction of epidermis and cutis
Excoriation: loss of substance of skin
due to scratching
Fissure: linear crack in skin surface
reaching dermis
Lichenification: Thickening of skin with
coarsening of skin markings
Secondary skin lesions:
21. History:
Age
When? Duration: Acute/chronic
Where it started?
Disease Site of first appearance
Measles Face – behind ears, near
hairline
Rubella Face
Erythema infectiosum Cheeks
Scarlet fever Neck
Exanthem subitum Trunk
22. Evolution and progression: Extension, exacerbation,
remission, recurrence Eg. In Chickenpox –pleomorphic,
in crops, centripetal
Distribution: Flexural (Atopic dermatitis), Extensor (HSP),
Areas exposed to sunlight or to chemicals
Type of lesion : Colour (Red, yellow, bluish), Fluid-filled,
purulent
When it begins to disappear: Typhoid, Urticaria – few
hours, Exanthem subitum – 24hrs, Measles – 4-5 days
Aggravating factors: (Photosensitivity, Urticaria, Eczema)
eg. Food, Contact with any chemicals/plants/other
substances, Sunlight, Heat/cold, sweating
History (cont..)
23. History (cont..)
Treatment history
Nutritional history
Past history of similar episodes, history of asthma,
urticaria
Similar history in close contacts: Viral exanthem,
scabies
Family history +ve: Atopic dermatitis, Psoriasis
Risk factors for HIV in parents
Social factors: Child abuse
24. h/o Occupation, H/o contact with allergens,
irritants,
h/o pets in home
H/o insect bite
H/o Drug intake (penicillin, sulpha drugs )
H/o immunosuppressive conditions
H/o Trauma
Cosmetic problem
History (cont..)
30. Distribution of rash:
a. Atopic dermatitis: flexural
b. Photodermatitis:
Sun-exposed areas
c. Extensors: HSP
31. Full exposure in natural light.
MORPHOLOGY-colour, size, consistency,margins, surface
characteristics.
DISTRIBUTION-flexor/extensor, sym/asymmetrical,
centrifugal/centripetel.
If only exposed areas involved?
Involvement of genitals/mucous membrane.
Examination of rash
35. MEASLES
Paramyxovirus.
IP—8 to 12 days.
Rash starts from face &
behind ears.
KOPLIKS SPOTS.
Diagnosis mostly clinical
H/o Fever, coryza followed by MP rashes
on 4th
day starting from face – near hairline
spreading to whole body
Common diseases with Rashes
36. Respiratory infections-otitis media croup,trachitis,bronchiolitis.
Abdominal pain – appendicitis due to swelling of Peyer
patches/hepatitis/gastroentritis
Pneumonia
Myocarditis, glomerulonephritis, thrombocytopenic purpura
Encephalitis (most serious)
Late onset: subacute sclerosing pan encephalitis (autoimmune
phenomenon)
Diarrhoea, malnutrition, Febrile seizures
MEASLES - COMPLICATIONS
37. No specific treatment
Hydration, antipyretics
Avoid intense light (for photophobia)
IV ribavirin (less role)
Vitamin A .
single dose of 2 lacs IU oral - >1 yr.
1 lac IU oral - 6 m to 1 yr
if opthalmologic evidence –repeat dose next day & 4
wks later.
Treatment of complications
MEASLES - TREATMENT
38. Rubella
RNA Togavirus
IP—2 to 3 weeks.
Most contagious-2 days prior to 6
days after rash
Face → neck → trunk.
Lymphadenopathy.
Forchheimers spots(20%)
39. Thrombocytopenia
Arthritis-clasically small hand joints
Encephalitis
Progressive rubella panencephalitis.
Others – GBS, peripheral neuritis,myocarditis.
Features of congenital rubella syndrome:
Intrauterine growth retardation, small for gestational age and failure
to thrive
Nerve deafness
Microcephaly and mental retardation
Congenital heart disease (PDA, VSD)
Cataract, glaucoma, and cloudy cornea
Thrombocytopenic purpura.
Hepatosplenomegaly,osteopathy,interstitial nephritis, pneumonitis.
Complications of Rubella
40. PRINCIPLE OF MANAGEMENT
of Rubella
TREATMENT
No specific therapy
Routine supportive care
Congenital Rubella Syndrome baby should
be isolated
41. PREVENTION
Live attenuated MMR vaccine
Children at age 12-15 months of life
In Nepal MR (measles and rubella) is given at 9
and 15 months.
Pregnant women are contraindicated for rubella
vaccine.
Pregnant woman should be immunized after
delivery.
42. Herpes virus varicellae
IP- 10 to 21 days
Papules→vesicles →crusting.
Pleomorphic,flexor surface.
Spreads centripetally,symmetrical,mucosa & axilla
involved,spares palm & soles,diminishes centrifugally.
Scab formation after 4-7 days.
Fever rises with each fresh crop of rash
Period of communicability is 2 days before
and 7 days after lesions crusted over.
Chickenpox
43. Secondary bacterial infections (staph/strep) most
common; may be life threatening with toxic shock
syndrome/necrotizing fasciitis
Varicella gangrenous – thrombocytopenia with
hemorrhagic lesions
Pneumonia, Myocarditis/pericarditis.
Hepatitis , Glomerulonephritis,Orchitis
Arthritis
Ulcerative gastritis
Encephalitis (cerebellar ataxia may occur without
encephalitis)
VARICELLA - COMPLICATIONS
44. Oral acyclovir- indications
Healthy nonpregnant teenagers and adults
Children > 1 yr with chronic cutaneous or
pulmonary conditions
Patients on chronic salicylate therapy
Patients receiving short or intermittent courses
of aerosolized corticosteroids
Treatment of complication
Varicella – Treatment
45. Erythrogenic toxin producing
group A β-hemolytic
streptococci
1 to 2 days after pharyngitis
Rash from neck- trunk- extremities,blanches on
pressure.
Petechiae in linear form.
More intense along elbow,axilla,groin creases.
Fade in 4 to 5 days with desquamation 1st
face progressing downwards.
White and red strawberry tongue
Treatment –penicillin or erythromycin
Scarlet Fever
46. < 5 yrs.
Staphylococcal exfoliation
Bullous lesions.
Easy peeling of skin in
thin sheets.
Positive Nikolsky’s sign
Diagnosis: Tzanck test, bacterial culture
Treatment:Penicillin is the drug of choice.
Staphylococcal Scalded-Skin
Syndrome
47. Superficial infection
of the dermis
Two types:
Impetigo contagiosa
Bullous impetigo
Etiology
Group A ß hemolytic streptococcus
Coagulase positive S. aureus
Treatment : Erythromycin is the drug of choice.
Impetigo
48. Multiple crusted
lesion with
erythematous halo
with polycyclic edges.
Spreads without healing.
Impetigo contagiosa
49. Stevens-Johnson Syndrome
Starts with fever,target lesions and mucosal
erosions.
Bulla > Erosions > Crustings.
Target lesions:Pale red centre with a pale zone
around it which is surrounded by dark red zone.
Skin tenderness is minimal to absent.
Pain due to mucosal ulceration.
Systemic involvement present .
Treatment : Nursing care , IVIg , Prevention of
secondary infection,care of eyes,mouth,
Systemic steroids.
50. Viral infections:
Herpes Simplex and Herpes Zoster
Vesicles in perioral
region
-Painful, grouped vesicles in
dermatomal distribution
51. Viral infections:
Caused by HPV B 19
Erythema over cheeks
Followed by itchy
maculopapular rash over trunk
and extensors of extremities
Erythema Infectiosum
52. Parasitic infestation
Papules and vesicles usually present in
Web spaces, wrist flexors, axilla, groin.
Head, palms, soles usually spared
Severe itching usually nocturnal
Presence of Burrow (Typical)
Similar h/o in other family members
Complication – secondary bacterial
infection, AGN, eczema
Treatment - Scabicide:
1.Permethrine
2.Benzyl Benzoate
3.Gamma benzoate hexachloride
4.Ivermectin.
Scabies
53. Rashes in Diaper area:
Rashes over the convex
surfaces of diaper area,
Over flexures
Beefy red
Satellite pustules
Irritant contact dermatitisCandidiasis
58. Henoch Schonlein purpura (HSP)Henoch Schonlein purpura (HSP)
appears as petechiae, palpable purpura over the buttocks & lowerappears as petechiae, palpable purpura over the buttocks & lower
extremities, as well as arthritis, abdominal pain,&extremities, as well as arthritis, abdominal pain,&
glomerulonephritisglomerulonephritis..
59. Investigations according to DiseaseInvestigations according to Disease
Diagnosis – usually clinical
CBC, PBS– TC (↑ in infections, HSP, Kawasaki,
May be ↓ in SLE), Eosinophilia in Scabies,
Platelets (↓ ITP, DIC, SLE; May be ↑ in IBD,
Kawasaki, HSP)
ESR - ↑ in infections, connective tissue disorders,
Kawasaki, IBD
Coagulation profiles (Bleeding spots)
Gram staining (Bacterial, Candidial)
Culture for bacteria or fungi (Saboraud Dextrose
agar)
Serology for infective organisms
60. InvestigationInvestigation
Direct light microscopy ( with
KOH preparation)
Dermatophytes
Parasitic infestations
Tzanck smear
HSV infection
Bullous disorders (Acantholytic
epidermal cells)
Immunofluorescence test
HSP (IgA around vessel walls)
61. InvestigationsInvestigations
Skin tests in allergy –
Intracutaneous, Patch test
Skin biopsy (HSP, Malignancy)
Dermatosonography
Tumours and subcutaneous
malignant lesions
Measurement and monitoring of
hemangiomas
62. Urine R/M/E: Hematuria, Proteinuria (SLE, HSP)
LP: Meningococcal
LFT, RFT - ↑ Urea, Creatinine in HSP, SLE
ANA, RA factor, Anti ds DNA – Connective tissue
disorders
HIV I & II
Stool R/M/E: IBD; Stool Occult blood – HSP,
Bleeding disorders
Creatine Kinase, LDH – Juvenile Dermatomyositis
Bone marrow examination: ITP, Leukemia
InvestigationsInvestigations
63. Management according to DiseaseManagement according to Disease
Specific management of condition
Viral fever with rash- acyclovir in chickenpox, or
symptomatic management of rash & fever.
Bacterial infections- systemic/ local antibiotics
Oral Cephalexin, Cloxacillin - generalized impetigo
Topical Mupirocin- Localised impetigo
Fungal infections- systemic/Local antifungal
agents
Eczema – Avoid the irritant, allergen,
Antihistaminic, local emollients, local steroids,
Cutaneous hydration
64. Management
Scabies- 25% Benzyl benzoate or Permethrine 5%
apply usually neck and below. Treat family members
too, wash and dry all clothes
Drug reactions – Stop the causative agent
Photosensitivity – Use of sunscreens
Psoriasis – Steroids, Keratolytic agents (5-10%
salicylic acid),Tar, UVB
Treatment of the systemic disease
65. References:
Nelson Textbook of Paediatrics, 18th
edition
O.P. Ghai Essential Paediatrics, 7th
edition
Fitzpatrick’s Dematology in General
medicine, 5th
edition.
Medscape
emedicine.com